Coherence Bio (prev. Opto Bio)
.png)
Developing a new class of biological interfaces for health insights and new treatment modalities.
LOCATION
Sectors
TechBio
Website
https://www.opto.bio/
Founders
Ben Woodington
Elise Jenkins
Coherence Bio is developing miniaturised implants that are safe, effective, and minimally invasive. Coherence believes that that the application of discreet, safe biological interfaces will enable remote and continuous neurological communication, changing the way we approach medicine by using the electrical language of the body. Advancing the frontiers of biological interfacing, Coherence is using new electrical biomarkers that can be used to inform disease state in real time. Coherence aims to improve patient outcomes and revolutionise precision treatment through their research, development, and clinical testing.
IN THE NEWS